Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, LEG, BFA, AVO, MAT

Greenery Map Offers Entirely Mobile Options for B2B, B2C, and Consumer Registration


LAS VEGAS, Aug. 21, 2019 /PRNewswire/ -- Greenery Map, the world's first and only cannabis search engine to allow users to search for cannabis products based on their desired mood, medicinal use, and method of consumption, is now offering users - both businesses and consumers - the opportunity to register and connect to the app in an entirely mobile way. Previously, businesses were required to access GreeneryMap.com from a desktop in order to manage accounts and connect to the inventory API system, but that road block has been removed, allowing for an entirely mobile experience through the Greenery Map app.

App users turn to Greenery Map to help them decide on the strain of Cannabis and product that is right for them depending on their desired mood or medicinal effect. Following the matching, consumers are given a detailed history and description of the strain so that they can make educated purchases, cutting down on time that budtenders need to spend with patrons and speeding up the purchase process. Consumers can then see all of the ways to purchase said product, including the nearby dispensaries that have it in stock, online options, and even delivery options through the app. Greenery Map fully integrates with a dispensary's inventory API system to update in real-time and give consumers real-time information on dispensary stock for the item they are looking for. The Greenery Map system also provides cannabis businesses in both the B2B and B2C sectors a private database to share and sell information and products. For Cannabis businesses, Greenery Map also offers the opportunity to open bank and merchant accounts through their partnership with PayHouse Consulting Group.

For more information, please visit: www.GreeneryMap.com and follow @GreeneryMap on social media.

About Greenery Map
Headquartered in Las Vegas, Greenery Map launched in 2018, giving marijuana consumers the quickest and easiest roadmap to finding their perfect strain. Greenery Map gives consumers the power to dictate exactly what they are looking for. By inputting consumption method, desired mood and medicinal need into the search engine, anyone from the novice to the connoisseur can find the strain that perfectly suits their needs, and the dispensaries that carry it, all in one place. For more information, please visit: www.GreeneryMap.com and follow @GreeneryMap.

 

Greenery Map logo (PRNewsfoto/Greenery Map)

SOURCE Greenery Map


These press releases may also interest you

at 07:19
Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced the inauguration of its new Research and Technology (R&T) Centre in Hyderabad, India. Sri K T Rama Rao, Hon'ble Minister...

at 03:25
Can't choose between WP Engine and Bluehost? The team of experts over at Web Create have shared a comparison and review of these two popular web hosting companies, providing a comprehensive side-by-side analysis to help those who are looking to...

at 03:00
USA's HashCash Consultants has partnered with a leading crypto exchange and digital assets trading platform, to aid them in building supporting infrastructure to streamline the trading activities. They will help the latter by integrating an advanced...

at 03:00
Known for their extensive and innovative offering of blockchain solutions for banks and financial institutions, HashCash Consultants is collaborating with a global financial institution to help them streamline their commercial lending infrastructure...

at 03:00
The acceleration of crypto dominance globally has pushed many retailers and eCommerce enterprises to include crypto payments within their modules. On a similar note, leading blockchain and crypto development company, HashCash Consultants has...

at 02:45
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Enspryngtm (satralizumab-mwge) as the first and only subcutaneous treatment for adults living with...



News published on 21 august 2019 at 12:29 and distributed by: